| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |